Business Wire

Revelation Biosciences Inc. Announces the Start of a Phase 1 Clinical Study for REVTx‑99, an Experimental Treatment for Respiratory Viral Infection, Including COVID‑19

MENLO PARK, Calif.--(BUSINESS WIRE)--Revelation Biosciences Inc. (Revelation), a clinical stage life sciences company focused on the development of immunologic-based therapies for the prevention and ...
Yahoo Finance

Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI

SAN DIEGO, CA / ACCESS Newswire / January 21, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing ...
Business Wire

Revelation Biosciences Inc. Receives Approval to Start a Phase 1 Clinical Study of REVTx-99 an Experimental Treatment for COVID-19

MENLO PARK, Calif.--(BUSINESS WIRE)--Revelation Biosciences Inc. (Revelation), a clinical stage life sciences company focused on the development of immunologic-based therapies for the prevention and ...